Sept 30 (Reuters) - GRI Bio Inc :
* GRI BIO GRANTED JAPAN PATENT FOR PROPRIETARY NATURAL KILLER T (NKT) CELL MODULATORS FOR PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS
* GRI BIO INC - RECEIVES PATENT GRANT NOTICE FROM JAPAN PATENT OFFICE
* GRI BIO INC - INTERIM DATA EXPECTED IN Q4 2024, TOPLINE DATA IN Q1 2025
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments